|
1
|
Mommersteeg MT, Yeh ML, Parnavelas JG and
Andrews WD: Disrupted Slit-Robo signalling results in membranous
ventricular septum defects and bicuspid aortic valves. Cardiovasc
Res. 106:55–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weyers JJ, Milutinovich AB, Takeda Y, Jemc
JC and Van Doren M: A genetic screen for mutations affecting gonad
formation in Drosophila reveals a role for the slit/robo pathway.
Dev Biol. 353:217–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dickinson RE, Hryhorskyj L, Tremewan H,
Hogg K, Thomson AA, McNeilly AS and Duncan WC: Involvement of the
SLIT/ROBO pathway in follicle development in the fetal ovary.
Reproduction. 139:395–407. 2010. View Article : Google Scholar :
|
|
4
|
Piper M, Georgas K, Yamada T and Little M:
Expression of the vertebrate Slit gene family and their putative
receptors, the Robo genes, in the developing murine kidney. Mech
Dev. 94:213–217. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang PH, Hwang-Verslues WW, Chang YC,
Chen CC, Hsiao M, Jeng YM, Chang KJ, Lee EY, Shew JY and Lee WH:
Activation of Robo1 signaling of breast cancer cells by Slit2 from
stromal fibroblast restrains tumorigenesis via blocking
PI3K/Akt/β-catenin pathway. Cancer Res. 72:4652–4661. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marlow R, Strickland P, Lee JS, Wu X,
Pebenito M, Binnewies M, Le EK, Moran A, Macias H, Cardiff RD, et
al: SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4
within breast epithelium. Cancer Res. 68:7819–7827. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Göhrig A, Detjen KM, Hilfenhaus G, Körner
JL, Welzel M, Arsenic R, Schmuck R, Bahra M, Wu JY, Wiedenmann B,
et al: Axon guidance factor SLIT2 inhibits neural invasion and
metastasis in pancreatic cancer. Cancer Res. 74:1529–1540. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mano Y, Aishima S, Fukuhara T, Tanaka Y,
Kubo Y, Motomura T, Toshima T, Iguchi T, Shirabe K, Maehara Y, et
al: Decreased roundabout 1 expression promotes development of
intrahepatic cholangiocarcinoma. Hum Pathol. 44:2419–2426. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Werbowetski-Ogilvie TE, Seyed Sadr M,
Jabado N, Angers-Loustau A, Agar NY, Wu J, Bjerkvig R, Antel JP,
Faury D, Rao Y, et al: Inhibition of medulloblastoma cell invasion
by Slit. Oncogene. 25:5103–5112. 2006.PubMed/NCBI
|
|
10
|
Mertsch S, Schmitz N, Jeibmann A, Geng JG,
Paulus W and Senner V: Slit2 involvement in glioma cell migration
is mediated by Robo1 receptor. J Neurooncol. 87:1–7. 2008.
View Article : Google Scholar
|
|
11
|
Xu Y, Li WL, Fu L, Gu F and Ma YJ:
Slit2/Robo1 signaling in glioma migration and invasion. Neurosci
Bull. 26:474–478. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yiin JJ, Hu B, Jarzynka MJ, Feng H, Liu
KW, Wu JY, Ma HI and Cheng SY: Slit2 inhibits glioma cell invasion
in the brain by suppression of Cdc42 activity. Neuro Oncol.
11:779–789. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang QQ, Zhou DL, Lei Y, Zheng L, Chen
SX, Gou HJ, Gu QL, He XD, Lan T, Qi CL, et al: Slit2/Robo1
signaling promotes intestinal tumorigenesis through Src-mediated
activation of the Wnt/β-catenin pathway. Oncotarget. 6:3123–3135.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou WJ, Geng ZH, Chi S, Zhang W, Niu XF,
Lan SJ, Ma L, Yang X, Wang LJ, Ding YQ, et al: Slit-Robo signaling
induces malignant transformation through Hakai-mediated E-cadherin
degradation during colorectal epithelial cell carcinogenesis. Cell
Res. 21:609–626. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang XM, Han HX, Sui F, Dai YM, Chen M and
Geng JG: Slit-Robo signaling mediates lymphangiogenesis and
promotes tumor lymphatic metastasis. Biochem Biophys Res Commun.
396:571–577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang LJ, Zhao Y, Han B, Ma YG, Zhang J,
Yang DM, Mao JW, Tang FT, Li WD, Yang Y, et al: Targeting
Slit-Roundabout signaling inhibits tumor angiogenesis in
chemical-induced squamous cell carcinogenesis. Cancer Sci.
99:510–517. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qi C, Lan H, Ye J, Li W, Wei P, Yang Y,
Guo S, Lan T, Li J, Zhang Q, et al: Slit2 promotes tumor growth and
invasion in chemically induced skin carcinogenesis. Lab Invest.
94:766–776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao R, Zhao Y, Wang LJ and Li WP: Effects
of Roundabout 5 on adhesion, invasion and potential motility of
human tongue carcinoma Tb cells. Chin Med J (Engl). 124:2367–2371.
2011.
|
|
19
|
Prasad A, Fernandis AZ, Rao Y and Ganju
RK: Slit protein-mediated inhibition of CXCR4-induced chemotactic
and chemoinvasive signaling pathways in breast cancer cells. J Biol
Chem. 279:9115–9124. 2004. View Article : Google Scholar
|
|
20
|
Zhang C, Guo H, Li B, Sui C, Zhang Y, Xia
X, Qin Y, Ye L, Xie F, Wang H, et al: Effects of Slit3 silencing on
the invasive ability of lung carcinoma A549 cells. Oncol Rep.
34:952–960. 2015.PubMed/NCBI
|
|
21
|
Jin J, You H, Yu B, Deng Y, Tang N, Yao G,
Shu H, Yang S and Qin W: Epigenetic inactivation of SLIT2 in human
hepatocellular carcinomas. Biochem Biophys Res Commun. 379:86–91.
2009. View Article : Google Scholar
|
|
22
|
Wurmbach E, Chen YB, Khitrov G, Zhang W,
Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, et
al: Genome-wide molecular profiles of HCV-induced dysplasia and
hepatocellular carcinoma. Hepatology. 45:938–947. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mas VR, Maluf DG, Archer KJ, Yanek K, Kong
X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P, et al:
Genes involved in viral carcinogenesis and tumor initiation in
hepatitis C virus-induced hepatocellular carcinoma. Mol Med.
15:85–94. 2009. View Article : Google Scholar
|
|
24
|
Roessler S, Jia HL, Budhu A, Forgues M, Ye
QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX, et al: A
unique metastasis gene signature enables prediction of tumor
relapse in early-stage hepatocellular carcinoma patients. Cancer
Res. 70:10202–10212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S,
Guo X, Wang B, Gang Y, Zhang Y, et al: MiR-218 inhibits invasion
and metastasis of gastric cancer by targeting the Robo1 receptor.
PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: MiR-218
suppresses nasopharyngeal cancer progression through downregulation
of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 71:2381–2391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gu JJ, Gao GZ and Zhang SM: miR-218
inhibits the migration and invasion of glioma U87 cells through the
Slit2-Robo1 pathway. Oncol Lett. 9:1561–1566. 2015.PubMed/NCBI
|
|
28
|
Cho SB, Park YL, Park SJ, Park SY, Lee WS,
Park CH, Choi SK, Heo YH, Koh YS, Cho CK, et al: KITENIN is
associated with activation of AP-1 target genes via MAPK cascades
signaling in human hepatocellular carcinoma progression. Oncol Res.
19:115–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang X, Huang S, Zhang F, Han X, Miao L,
Liu Z, Fan Z and Ji G: Lentiviral-mediated Smad4 RNAi promotes
SMMC-7721 cell migration by regulation of MMP-2, VEGF and MAPK
signaling. Mol Med Rep. 3:295–299. 2010.
|
|
30
|
Zhu B, Shi S, Ma YG, Fan F and Yao ZZ:
Lysophosphatidic acid enhances human hepatocellular carcinoma cell
migration, invasion and adhesion through P38 MAPK pathway.
Hepatogastroenterology. 59:785–789. 2012.
|
|
31
|
Chen JS, Wang Q, Fu XH, Huang XH, Chen XL,
Cao LQ, Chen LZ, Tan HX, Li W, Bi J, et al: Involvement of
PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in
hepatocellular carcinoma: Association with MMP-9. Hepatol Res.
39:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li X, Yang Z, Song W, Zhou L, Li Q, Tao K,
Zhou J, Wang X, Zheng Z, You N, et al: Overexpression of Bmi-1
contributes to the invasion and metastasis of hepatocellular
carcinoma by increasing the expression of matrix metalloproteinase
(MMP)-2, MMP-9 and vascular endothelial growth factor via the
PTEN/PI3K/Akt pathway. Int J Oncol. 43:793–802. 2013.PubMed/NCBI
|
|
33
|
Xu J, Jia L, Ma H, Li Y, Ma Z and Zhao Y:
Axl gene knockdown inhibits the metastasis properties of
hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway. Tumour
Biol. 35:3809–3817. 2014. View Article : Google Scholar
|
|
34
|
Maiti GP, Ghosh A, Mondal P, Ghosh S,
Chakraborty J, Roy A, Roychowdhury S and Panda CK: Frequent
inactivation of SLIT2 and ROBO1 signaling in head and neck lesions:
Clinical and prognostic implications. Oral Surg Oral Med Oral
Pathol Oral Radiol. 119:202–212. 2015. View Article : Google Scholar
|
|
35
|
Nones K1, Waddell N, Song S, Patch AM,
Miller D, Johns A, Wu J, Kassahn KS, Wood D, Bailey P, et al:
Genome-wide DNA methylation patterns in pancreatic ductal
adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2
and MET signaling. Int J Cancer. 135:1110–1118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ma WJ, Zhou Y, Lu D, Dong D, Tian XJ, Wen
JX and Zhang J: Reduced expression of Slit2 in renal cell
carcinoma. Med Oncol. 31:7682014. View Article : Google Scholar
|
|
37
|
Kim GE1, Lee KH, Choi YD, Lee JS, Lee JH,
Nam JH, Choi C, Park MH and Yoon JH: Detection of Slit2 promoter
hypermethylation in tissue and serum samples from breast cancer
patients. Virchows Archiv. 459:383–390. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dunwell TL, Dickinson RE, Stankovic T,
Dallol A, Weston V, Austen B, Catchpoole D, Maher ER and Latif F:
Frequent epigenetic inactivation of the SLIT2 gene in chronic and
acute lymphocytic leukemia. Epigenetics. 4:265–269. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dallol A, Krex D, Hesson L, Eng C, Maher
ER and Latif F: Frequent epigenetic inactivation of the SLIT2 gene
in gliomas. Oncogene. 22:4611–4616. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Toth M, Chvyrkova I, Bernardo MM,
Hernandez-Barrantes S and Fridman R: Pro-MMP-9 activation by the
MT1-MMP/MMP-2 axis and MMP-3: Role of TIMP-2 and plasma membranes.
Biochem Biophys Res Commun. 308:386–395. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chung TW, Lee YC and Kim CH: Hepatitis B
viral HBx induces matrix metalloproteinase-9 gene expression
through activation of ERK and PI-3K/AKT pathways: Involvement of
invasive potential. FASEB J. 18:1123–1125. 2004.PubMed/NCBI
|
|
42
|
Chen F, Deng J, Liu X, Li W and Zheng J:
HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated
up-regulation of MMP-2 with prognostic significance in human renal
cell carcinoma. Sci Rep. 5:134702015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cheng JC, Chou CH, Kuo ML and Hsieh CY:
Radiation-enhanced hepatocellular carcinoma cell invasion with
MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction
pathway. Oncogene. 25:7009–7018. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang B, Dietrich UM, Geng JG, Bicknell R,
Esko JD and Wang L: Repulsive axon guidance molecule Slit3 is a
novel angiogenic factor. Blood. 114:4300–4309. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Paul JD, Coulombe KL, Toth PT, Zhang Y,
Marsboom G, Bindokas VP, Smith DW, Murry CE and Rehman J:
SLIT3-ROBO4 activation promotes vascular network formation in human
engineered tissue and angiogenesis in vivo. J Mol Cell Cardiol.
64:124–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
